STERIS (STE) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

STE Stock Forecast


STERIS (STE) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $271.33, with a high of $275.00 and a low of $269.00. This represents a 26.15% increase from the last price of $215.09.

$200 $215 $230 $245 $260 $275 High: $275 Avg: $271.33 Low: $269 Last Closed Price: $215.09

STE Stock Rating


STERIS stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (85.71%), 2 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 2 12 Strong Sell Sell Hold Buy Strong Buy

STE Price Target Upside V Benchmarks


TypeNameUpside
StockSTERIS26.15%
SectorHealthcare Stocks 15.45%

Price Target Trends


1M3M12M
# Anlaysts-13
Avg Price Target-$275.00$271.33
Last Closing Price$215.09$215.09$215.09
Upside/Downside-27.85%26.15%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 26243--9
Aug, 26342--9
Jul, 26332--8
Jun, 26332--8
May, 26232-18
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 28, 2026Patrick WoodUBS$275.00$218.4025.92%27.85%
May 21, 2026Jason BednarPiper Sandler$270.00$216.1824.90%25.53%
May 13, 2026Brett FishbinKeyBanc$269.00$210.8527.58%25.06%
Oct 24, 2024Jason BednarPiper Sandler$260.00$221.1517.57%20.88%
Sep 03, 2024Brett FishbinKeyBanc$265.00$241.109.91%23.20%
May 10, 2024Jason BednarPiper Sandler$225.00$225.95-0.42%4.61%
Apr 04, 2024Mike PolarkWolfe Research$245.00$216.6513.09%13.91%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Jul 28, 2026UBSBuyinitialise
May 21, 2026Piper SandlerOverweightOverweighthold
May 13, 2026KeyBancOverweightOverweighthold
Jul 15, 2025Morgan StanleyEqual-WeightOverweightupgrade
May 29, 2025JefferiesHoldinitialise
May 16, 2025CitigroupOutperformOutperformhold
Feb 03, 2025Piper SandlerOverweightOverweighthold
Oct 24, 2024StephensMarket OutperformMarket Outperformhold
Oct 24, 2024Piper SandlerNeutralOverweightupgrade
Sep 03, 2024StephensMarket OutperformMarket Outperformhold

Financial Forecast


EPS Forecast

$0 $3 $6 $9 $12 $15 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27
Reported$2.50$1.07$3.83$6.24$7.93-
Avg Forecast$7.90$8.05$8.60$9.13$10.05$10.91
High Forecast$7.96$8.10$8.66$9.15$10.23$11.99
Low Forecast$7.86$8.00$8.59$9.10$9.93$9.88
Surprise %-68.35%-86.71%-55.47%-31.65%-21.09%-

Revenue Forecast

$4B $5B $5B $6B $6B $7B Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27
Reported$4.22B$4.54B$5.14B$5.46B$5.94B-
Avg Forecast$4.55B$4.85B$5.45B$5.50B$5.82B$6.17B
High Forecast$4.57B$4.87B$5.46B$5.51B$5.85B$6.18B
Low Forecast$4.53B$4.82B$5.44B$5.47B$5.80B$6.16B
Surprise %-7.14%-6.39%-5.63%-0.68%1.98%-

Net Income Forecast

$0 $300M $600M $900M $1B $2B Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27
Reported$243.89M$107.03M$378.24M$614.64M$785.10M-
Avg Forecast$273.12M$799.67M$566.84M$907.08M$1.00B$1.09B
High Forecast$334.96M$804.62M$694.42M$909.57M$1.02B$1.19B
Low Forecast$211.29M$794.57M$439.26M$904.59M$987.06M$981.42M
Surprise %-10.70%-86.62%-33.27%-32.24%-21.64%-

STE Forecast FAQ


Is STERIS stock a buy?

STERIS stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 12 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that STERIS is a favorable investment for most analysts.

What is STERIS's price target?

STERIS's price target, set by 14 Wall Street analysts, averages $271.33 over the next 12 months. The price target range spans from $269 at the low end to $275 at the high end, suggesting a potential 26.15% change from the previous closing price of $215.09.

How does STERIS stock forecast compare to its benchmarks?

STERIS's stock forecast shows a 26.15% upside, outperforming the average forecast for the healthcare stocks sector (15.45%).

What is the breakdown of analyst ratings for STERIS over the past three months?

  • September 2026: 22.22% Strong Buy, 44.44% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 33.33% Strong Buy, 44.44% Buy, 22.22% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 37.50% Strong Buy, 37.50% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is STERIS’s EPS forecast?

STERIS's average annual EPS forecast for its fiscal year ending in March 2027 is $10.91, marking a 37.58% increase from the reported $7.93 in 2026..

What is STERIS’s revenue forecast?

STERIS's average annual revenue forecast for its fiscal year ending in March 2027 is $6.17B, reflecting a 3.93% increase from the reported $5.94B in 2026.

What is STERIS’s net income forecast?

STERIS's net income forecast for the fiscal year ending in March 2027 stands at $1.09B, representing an 38.39% increase from the reported $785.1M in 2026.